Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT02740556
Eligibility Criteria:
No one will be excluded based on gender, age, race, or ethnic group.
Inclusion criteria Phase 1 and 2:
* Age18 years and older
* Being prescribed Harvoni for treatment of HCV and not yet started treatment
* Speak and read English
Inclusion criteria Phase 2 Only:
* Possessing a smartphone device
* Ability to use a smartphone device
* Registered with a physician currently using the HepCure Provider Dashboard.
* Speak and read English
Exclusion criteria:
* Individuals with diminished mental capacity who are unable to give informed consent
* Prisoners
* Participants who do not speak or write in English as a primary language
* Participants who are unable to speak and read English
* Participants who are expected to have difficult with regular access to smart phone device.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
89 Years
Study:
NCT02740556
Study Brief:
Protocol Section:
NCT02740556